109 related articles for article (PubMed ID: 31232274)
1. Investigation of bioequivalence, safety, and tolerability of a fixed-dose combination of nifedipine GITS and candesartan compared with the corresponding loose-dose combination under fed conditions
.
Thomas D; Liu Y; Stein H; Weimann B
Int J Clin Pharmacol Ther; 2019 Aug; 57(8):420-428. PubMed ID: 31232274
[TBL] [Abstract][Full Text] [Related]
2. Investigation of bioequivalence of a new fixed-dose combination of nifedipine and candesartan with the corresponding loose combination as well as the drug-drug interaction potential between both drugs under fasting conditions.
Brendel E; Weimann B; Dietrich H; Froede C; Thomas D
Int J Clin Pharmacol Ther; 2013 Sep; 51(9):753-62. PubMed ID: 23849325
[TBL] [Abstract][Full Text] [Related]
3. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and bioequivalence study comparing a candesartan cilexetil/rosuvastatin calcium fixed-dose combination with the concomitant administration of candesartan cilexetil and rosuvastatin calcium in healthy Korean subjects
.
Park DB; Jang K; Lee JW; Park CW; Lee BH; Kim MG; Jeon JY
Int J Clin Pharmacol Ther; 2017 Mar; 55(3):286-294. PubMed ID: 28079517
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and safety of nifedipine GITS/candesartan fixed-dose combination in subjects with hepatic impairment
.
Liu Y; Boettcher MF; Schmidt A; Unger S; Halabi A; Brendel E; Blode H
Int J Clin Pharmacol Ther; 2017 Mar; 55(3):246-255. PubMed ID: 28025965
[TBL] [Abstract][Full Text] [Related]
6. Fixed-dose combination of nifedipine gastrointestinal therapeutic system and candesartan cilexetil in patients with moderate-to-severe essential hypertension: an open-label, long-term safety and efficacy study.
Kjeldsen SE; Dzongowski P; Li N; Wang L; Radlmaier A
J Clin Pharm Ther; 2016 Dec; 41(6):695-702. PubMed ID: 27670639
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic Comparison of a Fixed-Dose Combination of Candesartan Cilexetil/Amlodipine/Atorvastatin Versus Co-administration of Individual Formulations in Healthy Participants.
Kim JH; Song JH; Kim M; Hong JH; Sunwoo J; Jung JG
Adv Ther; 2024 Jul; 41(7):2808-2825. PubMed ID: 38771476
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed Conditions.
Wu L; Xu C; Wu G; Zhou H; Lv D; Zhai Y; Huang Y; Tang W; Li F; Shentu J
Drug Des Devel Ther; 2019; 13():3331-3342. PubMed ID: 31571834
[TBL] [Abstract][Full Text] [Related]
9. Linagliptin fixed-dose combination with metformin is bioequivalent to co-administration of linagliptin and metformin as individual tablets.
Buschke S; Ring A; Friedrich C; Metzmann K; Meinicke T
Int J Clin Pharmacol Ther; 2014 Jul; 52(7):537-48. PubMed ID: 24755123
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects.
Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; La S; Kim HJ; Cho S; Yoon YR; Yang DH; Lee HW
Drug Des Devel Ther; 2018; 12():545-553. PubMed ID: 29559771
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of a new fixed-dose combination of candesartan cilexetil, hydrochlorothiazide, and rosuvastatin in healthy adult subjects.
Yerino GA; Feleder EC; Halabe EK; Diaz L; Sakson M; Iglesias M; Haddad T; Roldán E; Mondelo N
Int J Clin Pharmacol Ther; 2022 Apr; 60(4):192-206. PubMed ID: 35103587
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and Bioequivalence Studies of a Newly Developed Branded Generic of Candesartan Cilexetil Tablets in Healthy Volunteers.
Patel R; Palmer JL; Joshi S; Di Ció Gimena A; Esquivel F
Clin Pharmacol Drug Dev; 2017 Sep; 6(5):492-498. PubMed ID: 27753282
[TBL] [Abstract][Full Text] [Related]
13. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.
Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C
Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence for a Fixed-Dose Combination Formulation of Bazedoxifene and Cholecalciferol Compared With the Corresponding Single Entities Given Together.
Yun JN; Kan HS; Yeun JS; Kim JH; Lee M; Kim N; Oh TY; Nam SK; Choi YS; Kwon IS; Hoe KL; Hong JH
Clin Pharmacol Drug Dev; 2021 Aug; 10(8):850-858. PubMed ID: 34190419
[TBL] [Abstract][Full Text] [Related]
15. Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials.
Godfrey AR; Digiacinto J; Davis MW
Clin Ther; 2011 Jun; 33(6):766-75. PubMed ID: 21704241
[TBL] [Abstract][Full Text] [Related]
16. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
Anschütz M; Wonnemann M; Schug B; Toal C; Donath F; Pontius A; Pauli K; Brendel E; Blume H
Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence and food effect of a fixed-dose combination of macitentan and tadalafil: Adaptive design in the COVID-19 pandemic.
Csonka D; Fishman V; Natarajan J; Stieltjes H; Armas D; Dishy V; Perez Ruixo JJ
Pharmacol Res Perspect; 2021 Oct; 9(5):e00846. PubMed ID: 34624174
[TBL] [Abstract][Full Text] [Related]
18. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
Park SI; Lee H; Oh J; Lim KS; Jang IJ; Kim JA; Jung JH; Yu KS
Drug Des Devel Ther; 2015; 9():729-36. PubMed ID: 25678778
[TBL] [Abstract][Full Text] [Related]
19. A Phase I Study to Show the Relative Bioavailability and Bioequivalence of Fixed-Dose Combinations of Ambrisentan and Tadalafil in Healthy Subjects.
Okour M; Puri A; Chen G; Port K; Berni A; Khindri S; Schneider I; Tenero D
Clin Ther; 2019 Jun; 41(6):1110-1127. PubMed ID: 31060740
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjects.
Lee HW; Kang WY; Jung W; Gwon MR; Yang DH; Kim EH; Cho K; Yoon YR; Seong SJ
Transl Clin Pharmacol; 2020 Jun; 28(2):92-101. PubMed ID: 32656160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
